Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belbuca for Moderate to Severe Chronic Pain
NCT01755546Phase 3Completed
- Sponsor
- BioDelivery Sciences International
- Start
- Dec 2012
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of BEMA buprenorphine in chronic pain, low back pain (LBP), osteoarthritis (OA), neuropathic pain, sponsored by BioDelivery Sciences International. Started Dec 2012; status: completed.
02
Drugs
BEMA buprenorphine
03
Conditions
chronic painlow back pain (LBP)osteoarthritis (OA)neuropathic pain
Beyond the preview
Go deeper on NCT01755546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755546.